Evaluation of a Dual Action Pneumatic Compression Device: Patient Ease of Use and Comfort

Subjects will be randomized to receive either the ACTitouch system or standard compression
garments, and will respond to symptom surveys and quality of life surveys to assess comfort
and ease of use of each. These will be conducted at Baseline, at Day 15 and Day 30.

Inclusion Criteria:

- Diagnosis of unilateral or bilateral CVI with or without leg ulcers

- Documented history of low adherence to compression garment therapy

- CEAP classification C3-C6

- Leg circumferences within the following ranges: Ankle 12-44cm, calf 22-6m, below the
knee 22-68cm

Exclusion Criteria:

- History of skin sensitivity to any of the components of ACTitouch or compression
garments

- History of acute (deep vein thrombosis) DVT or (pulmonary embolism) PE within the
last 3 months

- Ankle Brachial Index (ABI) < 0.8

- Acute thrombophlebitis

- History of pulmonary edema or decompensated congestive heart failure

- Currently has an active infection of the skin such as cellulitis requiring
antibiotics

- Poorly controlled diabetes with an HbA1c value of >10%

- Exhibits any condition which, according to the PI, justifies the subjects exclusion
from the study, such as a medical condition where an increase in venous or lymphatic
return is undesirable.

- Subjects with open ulcers must be le to follow their care regimen for ulcer healing
concurrently with the assigned study regimen.

- Participating in another clinical trial

- Changes to medications that affect edema within the last 30 days

- Currently pregnant or trying to become pregnant